Stevanato Group S.p.A. (STVN) to Issue Annual Dividend of €0.05 on July 29th

Stevanato Group S.p.A. (NYSE:STVN) announced an annual dividend on Friday, April 10th. Stockholders of record on Thursday, June 11th will be paid a dividend of 0.054 per share on Wednesday, July 29th. This represents a dividend yield of 29.0%. The ex-dividend date is Thursday, June 11th.

Stevanato Group has a payout ratio of 8.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Stevanato Group to earn $0.80 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 7.5%.

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €18.02 on Tuesday. The business’s 50 day simple moving average is €16.49 and its 200-day simple moving average is €17.75. The firm has a market capitalization of $5.46 billion, a price-to-earnings ratio of 30.54, a price-to-earnings-growth ratio of 1.70 and a beta of 0.78. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.63 and a quick ratio of 1.11. Stevanato Group has a 12 month low of €12.89 and a 12 month high of €28.00.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01). The firm had revenue of €273.57 million for the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the business earned $0.10 earnings per share. As a group, equities analysts forecast that Stevanato Group will post 0.68 earnings per share for the current fiscal year.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.